Results 131 to 140 of about 5,811 (157)

Foscarnet☆

2007
openaire   +1 more source

Synthesis and Antiviral Evaluation of SATE-Foscarnet Prodrugs and New Foscarnet—AZT Conjugates

Antiviral Chemistry and Chemotherapy, 1998
Christian Perigaud, A M Aubertin, J P Sommadossi   +2 more
exaly  

Inhibition of cytomegalovirus late antigen expression and cytomegalovirus replication in human fibroblasts and differentiated monocytic cells by liposome-encapsulated foscarnet

Journal of Controlled Release, 1997
Irma A J M Bakker-Woudenberg, Ulrich R Hengge   +1 more
exaly  

Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failure

Journal of Clinical Virology, 2010
Charlotte Charpentier, Laurence Weiss, Florence Damond   +2 more
exaly  

Pharmacology and clinical use of foscarnet

International Journal of Antimicrobial Agents, 1995
Laurence Gérard
exaly  

Foscarnet

Reactions, 1987
openaire   +1 more source

Effects of foscarnet on the cell kinetics of Madin-Darby canine kidney cells

Biochimica Et Biophysica Acta - Molecular Cell Research, 1983
Sven Skog
exaly  

Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo

Antiviral Research, 1989
Thomas R Matthews
exaly  

A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients

Pediatric Blood and Cancer, 2007
Mitchell Cairo
exaly  

Emergence of cytomegalovirus resistance to foscarnet in a patient receiving foscarnet salvage therapy for multidrug-resistant HIV infection

Journal of Clinical Virology, 2012
David Boutolleau, Sonia Burrel, Anne-Genevieve Marcelin   +2 more
exaly